ASH News Daily is an annual meeting publication that is available to attendees on site each day. Belinda Avalos, M.D., of the Ohio State University Hospitals, is the Editor-in-Chief of this publication. Four separate issues of ASH News Daily, covering the four days of the 2005 ASH Annual Meeting, feature informative articles on a wide range of Education Program sessions, Scientific Committee sessions, and abstract presentations written by Dr. Avalos and the ASH News Daily author team, comprised of Drs. Laura de Castro, Francisca Gushiken, Thomas Lin, Jose Lopez, Craig Moskowitz, Elaine Muchmore, Stephen Nimer, John Pawlowski, Yuandong Peng, Richard Schwab, and Marilyn Telen.

The ASH News Daily online scientific summaries are supported by an educational grant from Bristol-Myers Squibb Company.

Issue I - Saturday, December 10, 2005

• Anemia and Aging: A Major Public Health Issue
• Chronic Myelogenous Leukemia: The Poster Child For the Molecular Era of Medicine
• CLL: Choosing the Right Treatment for the Individual Patient
• Gene Expression Profiling: Ready for Prime Time (or Not)?
• JAK of All Trades in MPDs
• Red Sacks Win World Series
• Sickle Cell Disease and Other Hemoglobinopathies: Can We Just Say "NO"?
• The Problem of Transplant-Eligible Patients Who Become Ineligible
• Tissue Factor: The Good, the Bad, and the Ugly
• Venous Thrombosis: What Causes It and How Do We Treat It?

Issue II - Sunday, December 11, 2005

• ASH/EHA Policy Forum: Challenges of Clinical Trials in the U.S. and EU
• Blood Banking 101: Better Safe Than Sorry
• Cancer Survivors Face Long-Term Challenges
• Lenalidomide for 5q-MDS: Targeted Therapy, but What's the Target?
• New Imatinib-Like Agents in CML
• Not Just BCL-2: Could BCL-6 Be a New Target for Lymphoma Therapy?
• Of Mice and Men: Inherited and Acquired Disorders of Platelet Function
• Reducing Liability Risks in Hematology Practice
• Rusty Pipes and Clogged Drains: Mechanisms of Atherosclerosis and Arterial Thrombosis
• Stem Cells Un"Bound"

Issue III - Monday, December 12, 2005

• A Sticky Situation: Platelet alphaIIbbeta3, From Structure to Clinical Applications
• Can You Believe It? 325 Abstracts on Rituximab
• CLL-1: The Holy Grail of AML?
• Ironing Out the Treatment of Overload in Sickle Cell Anemia
• Is There Hope for Older Patients with Myeloid Malignancies?
• JAK2 - Not Just Another Kinase
• NCI Announces New Initiative
• test.txt
• The E. Donnall Thomas Lecture: Passing of the Torch
• Tregs, CTLs, and DCs in Immune Reconstitution
• Watch Out Bortezomib, the Second Generation Is on Its Way!
• What Can the Hereditary Pediodic Fever Syndromes Tell Us About Innate Immunity?

Issue IV - Tuesday, December 13, 2005

• "Black Box" of Cancer Breaks Open: The William Dameshek Prize Is Awarded to Dr. John Dick
• Atypical Plasma Cell Syndromes: Not Just Myeloma
• Bleeding Disorders: Keeping the Pipes from Leaking
• Cascade of the Heart: Dr. Barry Coller Is Awarded the Henry M. Stratton Medal
• Education Spotlight Sessions - New Kid on the Block
• Eleanor Roosevelt - A Poster Child for Marrow Failure?
• Hodgkin Lymphoma: Less Still Better
• Is There Quality of Life After Stem Cell Transplantation?
• Mouse-ing Around: Defining Anemia Mechanisms
• Narcissistic but Responsible Stem Cells: Balancing Self Preservation and Their Commitments
• Presidential Symposium: Translating Biologic Insights into New Therapies
• The Changing World of Hematology Practice - Are You Ready?
• Vascular Wall Biology and Angiogenesis: New Branches for an Old Tree